Fig. 5.
![Fig. 5. Ca2+ responses of HPB.ALL subclones to TR agonists. CD45+ HPB.45.1 cells (□) or CD45-deficient HBP.45.0 cells (▨) were loaded with Indo-1 and stimulated with either 50 nmol/L thrombin or 120 μmol/L TFRIFD, and intracellular [Ca2+] was measured using a spectrofluorimeter. Values represent the mean ± SD of triplicate determinations.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/90/5/10.1182_blood.v90.5.1893/4/bl_0018f5.jpeg?Expires=1724234145&Signature=ZIgsc2uqH-L4VSJSws1mr1eGF49nrKu1cz~twvr9NCs0fyEYFHDpiwCU-LxZPhSAir9zSJ~kWv7lqO7ViOfMzld1DAbBXZizG3n8UzCMcrqzvRPa-f3OHQ0ddI9JeTSfWOhjJIWBcFRUX3NWzd9tVZ-hfEBFQN5DtGbgFryeindqMYMAZrDKQmg8K3H1xHzRg8~nh78RePJIBtPbNbA8m3T0O3gqJKTQXM5bJtRqsey4GrUWWTiYtGOJ8DjFod3Rpx48JFyb8fDm6yKayN2aHCBSUgvucuV8R8ehEw5B63fIk0EAZ07qxm25s~kDY103xpxaa~dYsh7zMwif1BjvXQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Ca2+ responses of HPB.ALL subclones to TR agonists. CD45+ HPB.45.1 cells (□) or CD45-deficient HBP.45.0 cells (▨) were loaded with Indo-1 and stimulated with either 50 nmol/L thrombin or 120 μmol/L TFRIFD, and intracellular [Ca2+] was measured using a spectrofluorimeter. Values represent the mean ± SD of triplicate determinations.
